ATE5797T1 - Immunostimulierende zusammensetzungen auf der basis von ribosomen rns von klebsiella pneumoniae und verfahren zur herstellung dieser rns. - Google Patents

Immunostimulierende zusammensetzungen auf der basis von ribosomen rns von klebsiella pneumoniae und verfahren zur herstellung dieser rns.

Info

Publication number
ATE5797T1
ATE5797T1 AT80401835T AT80401835T ATE5797T1 AT E5797 T1 ATE5797 T1 AT E5797T1 AT 80401835 T AT80401835 T AT 80401835T AT 80401835 T AT80401835 T AT 80401835T AT E5797 T1 ATE5797 T1 AT E5797T1
Authority
AT
Austria
Prior art keywords
rna
klebsiella pneumoniae
production
methods
ribosomic
Prior art date
Application number
AT80401835T
Other languages
German (de)
English (en)
Inventor
Lucien Dr. Doussourd D'hinterland
Gerard Normier
Anne-Marie Pinel
Jacques Durand
Original Assignee
Pierre Fabre S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre S.A. filed Critical Pierre Fabre S.A.
Application granted granted Critical
Publication of ATE5797T1 publication Critical patent/ATE5797T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT80401835T 1979-12-21 1980-12-19 Immunostimulierende zusammensetzungen auf der basis von ribosomen rns von klebsiella pneumoniae und verfahren zur herstellung dieser rns. ATE5797T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7931442A FR2471785A1 (fr) 1979-12-21 1979-12-21 Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
EP80401835A EP0031285B1 (fr) 1979-12-21 1980-12-19 Préparations immunostimulantes à base d'ARN ribosomaux de Klebsiella pneumoniae et procédé de préparation de ces ARN

Publications (1)

Publication Number Publication Date
ATE5797T1 true ATE5797T1 (de) 1984-01-15

Family

ID=9233074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80401835T ATE5797T1 (de) 1979-12-21 1980-12-19 Immunostimulierende zusammensetzungen auf der basis von ribosomen rns von klebsiella pneumoniae und verfahren zur herstellung dieser rns.

Country Status (11)

Country Link
US (1) US4389396A (OSRAM)
EP (1) EP0031285B1 (OSRAM)
JP (1) JPS56123918A (OSRAM)
AT (1) ATE5797T1 (OSRAM)
AU (1) AU538896B2 (OSRAM)
CA (1) CA1181703A (OSRAM)
DE (1) DE3066115D1 (OSRAM)
ES (1) ES8200229A1 (OSRAM)
FR (1) FR2471785A1 (OSRAM)
WO (1) WO1984000688A1 (OSRAM)
ZA (1) ZA807985B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
JPS61151128A (ja) * 1984-12-24 1986-07-09 Advance Res & Dev Co Ltd コレステロ−ル低下活性ｒｎａ画分
US4971801A (en) * 1986-06-09 1990-11-20 Cell Technology, Inc. Biologic response modifier
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
ES2052066T3 (es) * 1988-10-31 1994-07-01 Sandoz Nutrition Ltd Mejoras en o relacionadas con compuestos organicos.
US4997932A (en) * 1989-11-13 1991-03-05 Boehringer Mannheim Corporation Method and kit for purifying nucleic acids
FR2674755B1 (fr) * 1991-04-05 1995-02-03 Thorel Jean Noel Nouvelles compositions medicamenteuses immunostimulatrices.
FR2703252B1 (fr) * 1993-03-31 1996-09-06 Fernand Narbey Torossian Complexe immunomodulateur anti SIDA.
LT4475B (lt) * 1997-02-28 1999-02-25 Virmantas Stunžėnas Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse
FR2790960B1 (fr) * 1999-03-15 2002-10-31 Pf Medicament Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
AU2011244863B2 (en) * 2006-08-08 2013-03-21 Rheinische Friedrich-Wilhelms-Universitat Bonn Structure and use of 5' phosphate oligonucleotides
HUE037173T2 (hu) * 2006-08-08 2018-08-28 Univ Bonn Rheinische Friedrich Wilhelms 5'-Foszfát-oligonukleotidok szerkezete és alkalmazása
EP2338499A1 (en) * 2006-10-10 2011-06-29 Gunther Hartmann 5' triphosphate oligonucleotide induces anti-viral response
EP2297323A1 (en) 2008-05-21 2011-03-23 Hartmann, Gunther 5' triphosphate oligonucleotide with blunt end and uses thereof
EP2508530A1 (en) 2011-03-28 2012-10-10 Rheinische Friedrich-Wilhelms-Universität Bonn Purification of triphosphorylated oligonucleotides using capture tags
US9844592B2 (en) * 2011-07-18 2017-12-19 Icahn School Of Medicine At Mount Sinai Bacterial RNAs as vaccine adjuvants
EP2712870A1 (en) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Novel RIG-I ligands and methods for producing them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6513M (OSRAM) * 1967-07-12 1968-12-02
FR2253499B1 (OSRAM) 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2305990A1 (fr) 1975-04-02 1976-10-29 Fabre Sa Pierre Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens
FR2360314A2 (fr) 1976-08-06 1978-03-03 Fabre Sa Pierre Nouveaux vaccins perfectionnes a base de fractions ribosomales
FR2374911A1 (fr) 1976-12-21 1978-07-21 Fabre Sa Pierre Adjuvants d'immunite non specifique
FR2388563A1 (fr) 1977-04-29 1978-11-24 Fabre Sa Pierre Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Also Published As

Publication number Publication date
ES498476A0 (es) 1981-11-16
CA1181703A (en) 1985-01-29
EP0031285A3 (en) 1981-07-15
US4389396A (en) 1983-06-21
ZA807985B (en) 1982-01-27
EP0031285B1 (fr) 1984-01-11
JPS56123918A (en) 1981-09-29
FR2471785A1 (fr) 1981-06-26
DE3066115D1 (en) 1984-02-16
WO1984000688A1 (fr) 1984-03-01
AU538896B2 (en) 1984-08-30
EP0031285A2 (fr) 1981-07-01
ES8200229A1 (es) 1981-11-16
FR2471785B1 (OSRAM) 1982-11-05
AU6558880A (en) 1981-06-25

Similar Documents

Publication Publication Date Title
ATE5797T1 (de) Immunostimulierende zusammensetzungen auf der basis von ribosomen rns von klebsiella pneumoniae und verfahren zur herstellung dieser rns.
ATE973T1 (de) Verfahren zur herstellung von polyurethan-elastomeren.
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE3889393D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen.
DK164703C (da) Analogifremgangsmaade til fremstilling af kvaternaere 6,11-dihydro-dibenzo-oeb,eaa-thiepin-11-n-alkyl-norscopinethere og mellemprodukt til anvendelse ved denne fremgangsmaade
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
ATE4643T1 (de) Nitrothiophene, verfahren zur herstellung der verbindungen sowie fungizide und/oder bakterizide zusammensetzungen auf der basis dieser verbindungen.
IL61285A (en) 2-hydroxyalkyl-3,4,5-trihydroxy-piperidine compounds,their production and pharmaceutical compositions containing them
NO175313C (no) Joderte polymerer og deres anvendelse
IL58103A0 (en) Sila-substituted 1,4-dihydropyridine derivatives their production and pharmaceutical compositions containing them
IE822519L (en) Phosphonic acid derivatives
ATE3411T1 (de) Verfahren zur herstellung von 2,6dialkylcyclohexylaminen.
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE80802T1 (de) Verfahren und zusammensetzung zur behandlung von krebs und nichtmalignen tumoren.
JPS55105654A (en) Novel dehydropeptide compounds*their manufacture and their medical use
FI870873A0 (fi) Isohexid-nukleosid.
DE3784768D1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
IL65683A0 (en) Cyclic sulphenamide compounds,their production and pharmaceutical compositions containing them
EP0043976A3 (en) Anti-tumor agent
JPS5536485A (en) Nnaminoo3*4*55trihydoxypiperidines*their manufacture and use as drug
EP0285301A3 (en) Antitumor and antiviral furanoditerpenoids
DE3161400D1 (en) 5-alkyl-3-alkylthiopropionthioates, process for their preparation and their use as pharmaceutical compositions
ATE456T1 (de) Selektiv geschuetzte 4,6-d i-o-(aminoglykosyl)-1,3-diamino-cyclitole, verfahren zu deren herstellung und deren verwendung als zwischenprodukte.
ATE258T1 (de) Verfahren zur herstellung von 7,8-dichlor-1,2,3,4-tetrahydroisochinolin und zwischenprodukte.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time